Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >N-Nitroso Desmethyl Cidoxepin
N-Nitroso Desmethyl Cidoxepin
  • N-Nitroso Desmethyl Cidoxepin
  • N-Nitroso Desmethyl Cidoxepin
  • N-Nitroso Desmethyl Cidoxepin
  • N-Nitroso Desmethyl Cidoxepin
  • N-Nitroso Desmethyl Cidoxepin

N-Nitroso Desmethyl Cidoxepin NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: N-Nitroso Desmethyl Cidoxepin Min. Order: 10mg
Purity: 99%+ HPLC Supply Ability: 1000
Release date: 2025/07/31
Molecular formula: C18H18N2O2

N-Nitroso Desmethyl Cidoxepin

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

  • Product Number: N031080

  • English Name: N-Nitroso Desmethyl Cidoxepin

  • English Alias: (Z)-N-(3-(dibenzo[b,e]oxepin-11(6H)-ylidene)propyl)-N-methylnitrous amide

  • CAS Number: None

  • Molecular Formula: C₁₈H₁₈N₂O₂

  • Molecular Weight: 294.35

As a nitroso impurity of desmethyl cidoxepin, the research advantages of this compound lie in:


  • Analyzing the by-product formation mechanism of nitrosation reactions during cidoxepin metabolism or synthesis to optimize processes for controlling nitroso impurity generation;

  • Serving as a nitroso-class reference standard to provide a standard substance for detecting nitroso impurities in drugs, assisting in evaluating drug safety (nitroso compounds may have potential carcinogenicity);

  • Helping study the impact of nitroso structures on drug stability and toxicological properties to provide a scientific basis for formulating impurity control strategies.

  • Drug Development: Used as an impurity reference standard to identify and quantify N-nitroso impurities in cidoxepin preparations, evaluating the purity of APIs and metabolites;

  • Quality Control: Acting as a standard substance to validate the sensitivity of detection methods (e.g., HPLC or LC-MS), ensuring nitroso impurity content meets ICH guideline requirements during production;

  • Toxicological Research: Assisting in evaluating the potential genotoxicity of nitroso impurities to provide data support for drug safety evaluation.

Cidoxepin is an antidepressant drug, and its metabolites or synthesis may produce nitroso compounds. N-Nitroso Desmethyl Cidoxepin, as an impurity containing a nitroso structure, may be generated during demethylation reactions or storage. Due to the potential carcinogenic risk of nitroso compounds (such as N-nitrosamines), drug regulatory authorities worldwide have put forward strict control requirements for such impurities in drugs, making research on this impurity a key link in drug quality control and safety assessment.
Current research focuses on:


  • Synthesis Methods: Developing high-purity synthesis processes for (Z)-configured nitroso compounds to meet the needs of toxicological research and quality control;

  • Detection Technologies: Establishing trace detection methods for nitroso impurities (detection limits reach ppb level) using ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and other technologies;

  • Toxicological Evaluation: Studying the potential mutagenicity and carcinogenicity of this impurity through in vitro Ames tests and animal models;

  • Process Control: Analyzing the inducements (such as raw material residues, reaction conditions) of nitrosation reactions to optimize the synthesis route or storage conditions to reduce the generation of nitroso impurities


We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com




Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP1Y
Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd
2025-08-01
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-03-21
$1600.00/100mg
VIP2Y
R&D Scientific Inc.
2025-11-20
INQUIRY